GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (STU:CP60) » Definitions » Effective Interest Rate on Debt %

The Cooper (STU:CP60) Effective Interest Rate on Debt % : 4.25% (As of Apr. 2024)


View and export this data going back to 1983. Start your Free Trial

What is The Cooper Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. The Cooper's annualized positive value of Interest Expense for the quarter that ended in Apr. 2024 was €108 Mil. The Cooper's average total debt for the quarter that ended in Apr. 2024 was €2,537 Mil. Therefore, The Cooper's annualized Effective Interest Rate on Debt % for the quarter that ended in Apr. 2024 was 4.25%.


The Cooper Effective Interest Rate on Debt % Historical Data

The historical data trend for The Cooper's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Effective Interest Rate on Debt % Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.60 1.84 1.31 2.85 3.81

The Cooper Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.88 4.08 4.17 4.41 4.25

Competitive Comparison of The Cooper's Effective Interest Rate on Debt %

For the Medical Instruments & Supplies subindustry, The Cooper's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Effective Interest Rate on Debt % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where The Cooper's Effective Interest Rate on Debt % falls into.



The Cooper Effective Interest Rate on Debt % Calculation

The Cooper's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Oct. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Oct. 2022 )+Total Debt  (A: Oct. 2023 ))/ count )
=-1  *  -99.719/( (2804.851+2433.033)/ 2 )
=-1  *  -99.719/2618.942
=3.81 %

where

Total Debt  (A: Oct. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=2386.062 + 418.789
=2804.851

Total Debt  (A: Oct. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=2390.039 + 42.994
=2433.033

The Cooper's annualized Effective Interest Rate on Debt % for the quarter that ended in Apr. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jan. 2024 )+Total Debt  (Q: Apr. 2024 ))/ count )
=-1  *  -107.74/( (2544.972+2528.516)/ 2 )
=-1  *  -107.74/2536.744
=4.25 %

where

Total Debt  (Q: Jan. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=2502.652 + 42.32
=2544.972

Total Debt  (Q: Apr. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=2489.652 + 38.864
=2528.516

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Apr. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


The Cooper  (STU:CP60) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


The Cooper Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of The Cooper's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper (STU:CP60) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (STU:CP60) Headlines

No Headlines